PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Timing is everything in combination therapy for osteoporosis

2010-11-05
(Press-News.org) The adult human skeleton undergoes constant remodeling, with new bone forming at sites that have been broken down by a precise process called resorption. During remodeling, skeletal stem cells are recruited to resorption sites and directed to differentiate into bone-forming cells. Osteoporosis, a condition characterized by weak and fragile bones, develops when there is an imbalance in the remodeling process and more bone is lost than replaced. Now, new research published by Cell Press in the November issue of the journal Cell Stem Cell uncovers a mechanism that may guide development of better strategies for treatment osteoporosis.

Osteoporosis is often treated with drugs that inhibit bone resorption, such as alendronate, or drugs that stimulate bone formation, such as parathyroid hormone (PTH). Surprisingly, previous attempts to combine these approaches were not effective. "In clinical trials where PTH and alendronate were administered concurrently, the bone building effects of PTH were impaired," explains senior study author Dr. Xu Cao from The Johns Hopkins School of Medicine in Baltimore, MD. "This suggests that bone resorption is necessary for PTH-induced bone formation, but the underlying mechanisms are obscure. An improved understanding of the role that bone resorption plays in PTH-induced bone formation would provide a key mechanistic rationale for the development of strategies that maximize use of both PTH and antiresorptive drugs in the treatment of osteoporosis."

Dr. Cao's group had previously shown that transforming growth factor (TGF)-?1 plays a key role in bone formation after bone resorption. In the current study, the researchers identified a subset of skeletal stem cells that were recruited to bone remodeling sites in response to bone resorption. Importantly, the authors demonstrated the TGF-?1 is essential for recruitment of skeletal stem cells during PTH-stimulated bone remodeling. Further, alendronate inhibited release of TGF-?1 during bone resorption.

"Our research shows that inhibition of TGF-?1 activation by alendronate leads to insufficient recruitment of skeletal stem cells to resorptive sites for the new bone formation during PTH-stimulated bone remodeling," says Dr. Cao. "Given this mechanism, it is possible that the use of PTH before treatment by an antiresorptive drug like alendronate could be an effective therapy." Taken together, the findings help to explain why the order and timing of combination drug therapy may be critical for successful treatment of osteoporosis and may help to direct the design of future clinical trials.

###

The researchers include Xiangwei Wu, The Johns Hopkins University School of Medicine, Baltimore, MD, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China; Shihezi University, Shihezi, Xinjiang, China; Lijuan Pang, The Johns Hopkins University School of Medicine, Baltimore, MD, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China, Shihezi University, Shihezi, Xinjiang, China; Weiqi Lei, The Johns Hopkins University School of Medicine, Baltimore, MD William Lu, The University of Hong Kong, Hong Kong, China; Jun Li, The Johns Hopkins University School of Medicine, Baltimore, MD, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China; Shihezi University, Shihezi, Xinjiang, China; Zhaoyang Li, The University of Hong Kong, Hong Kong, China; Frank J. Frassica, The Johns Hopkins University School of Medicine, Baltimore, MD; Xueling Chen, The Johns Hopkins University School of Medicine, Baltimore, MD; Shihezi University, Shihezi, Xinjiang, China; Mei Wan, The Johns Hopkins University School of Medicine, Baltimore, MD and Xu Cao, The Johns Hopkins University School of Medicine, Baltimore, MD.

END



ELSE PRESS RELEASES FROM THIS DATE:

Human-specific evolution in battling bugs and building babies

2010-11-05
Although human and chimpanzee immune systems have many identical components, this is not the case for the family of killer cell immunoglobulin-like receptors (KIR) controlling white blood cells known as natural killer (NK) cells. Published in the open-access journal PloS Genetics on November 4, a paper by Stanford University researchers describes qualitative KIR differences, acquired after humans and chimpanzees separated 6 million years ago and mainly a consequence of innovation in the human line. These differences open up an exciting avenue for explaining the differential ...

No easy solution to genetic 'battle of the sexes'

No easy solution to genetic battle of the sexes
2010-11-05
A new study published today shows a genetic 'battle of the sexes' could be much harder to resolve and even more important to evolution than previously thought. This battle, observed across many species and known as intralocus sexual conflict, happens when the genes for a trait which is good for the breeding success of one sex are bad for the other – sparking an 'evolutionary tug-o-war' between the sexes. It has previously been thought these issues were only resolved when the trait in question evolves to become sex-specific in its development – meaning the trait only ...

Study reveals new genetic risk factor for both autism and schizophrenia

2010-11-05
ASDs include a range of neurodevelopmental conditions that are being diagnosed at an increasing rate. The Center for Disease Control and Prevention estimates that ASD currently affects 1 in 110 people. The prevalence of schizophrenia, with a diagnostic rate of 1 in 100 to 1 in 20, is similar. ASD and schizophrenia affect males more often than females, and both are thought to have a strong and overlapping genetic component. "The genetic overlap between ASD and schizophrenia, both of which have a high heritability, has been the focus of several recent studies; however, no ...

To prevent inbreeding, flowering plants have evolved multiple genes, research reveals

To prevent inbreeding, flowering plants have evolved multiple genes, research reveals
2010-11-05
A research team led by Teh-hui Kao, professor of biochemistry and molecular biology at Penn State University, in collaboration with a team lead by Professor Seiji Takayama at the Nara Institute of Science and Technology in Japan, has discovered a large suite of genes in the petunia plant that acts to prevent it from breeding with itself or with its close relatives, and to promote breeding with unrelated individuals. In much the same way that human inbreeding sometimes results in genetic disease and inferior health, some inbred plants also experience decreased fitness, and ...

Small protein changes may make big difference in natural HIV control

2010-11-05
Tiny variants in a protein that alerts the immune system to the presence of infection may underlie the rare ability of some individuals to control HIV infection without the need for medications. In a report that will appear in Science and is receiving early online release, an international research team led by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard and from the Broad Institute of MIT and Harvard describe finding that differences in five amino acids in a protein called HLA-B are associated with whether or not HIV-infected ...

Health registry could transform chronic kidney disease care

2010-11-05
A registry of health care information on patients with mild to moderate chronic kidney disease (CKD) could help physicians improve care for affected individuals, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that officials could use such a registry to develop a national surveillance system to identify and track various aspects of CKD. The incidence and health care costs of CKD are growing. A national reporting system that collects health care details on dialysis patients and ...

We've come a long way, researchers: How a decade of research is helping lupus patients

2010-11-05
Today, individuals with lupus nephritis benefit from better treatments than a decade ago, according to a review appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The article suggests that patients with the disease can now live full lives without suffering from many treatment-related side effects that plagued them in the past. In the future, patients will likely experience additional benefits from treatment strategies currently being explored in clinical trials. Individuals with the autoimmune disease systemic lupus erythematosus ...

Lasofoxifene reduces breast cancer risk in postmenopausal osteoporotic women

2010-11-05
Lasofoxifene statistically reduced the overall risk of breast cancer, as well as ER positive invasive breast cancer in postmenopausal women with low bone density, according to a study published online in The Journal of the National Cancer Institute. Lasofoxifene is a SERM, or selective estrogen receptor modulator, that, like tamoxifen, blocks the effects of estrogen in breast tissue. Another SERM, raloxifene, has been shown to reduce breast cancer risk. In the Postmenopausal Evaluation and Risk-Reduction with Lasofoxifene (PEARL) trial, a double-blind, placebo-controlled, ...

Obesity rate will reach at least 42 percent, say models of social contagion

2010-11-05
CAMBRIDGE, Mass. -- Researchers at Harvard University say America's obesity epidemic won't plateau until at least 42 percent of adults are obese, an estimate derived by applying mathematical modeling to 40 years of Framingham Heart Study data. Their work, published this week in the journal PLoS Computational Biology, runs counter to recent assertions by some experts that the obesity rate, which has been at 34 percent for the past five years, may have peaked. An additional 34 percent of American adults are overweight but not obese, according to the federal government's ...

Beneficial effects of testosterone for frailty in older men are short-lived

2010-11-05
Chevy Chase, MD—The beneficial effects of six months of testosterone treatment on muscle mass, strength and quality of life in frail elderly men are not maintained at six months post-treatment, according to a study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). Frailty is an age-related state of physical limitation caused by the loss of muscle mass and function and can lead to adverse clinical outcomes such as dependency, institutionalization and death. Testosterone levels naturally decline with aging and testosterone ...

LAST 30 PRESS RELEASES:

A graphene sandwich — deposited or transferred?

New light-powered motor fits inside a strand of hair

Oil rig study reveals vital role of tiny hoverflies

Children’s Hospital of Philadelphia researchers boost widespread use of dental varnish across pediatric network

iRECODE: A new computational method that brings clarity to single-cell analysis

New NUS-MOH study: Singapore’s healthcare sector carbon emissions 18% lower than expected, a milestone in the city-state’s net zero journey

QUT scientists create material to turn waste heat into clean power

Major new report sets out how to tackle the ‘profound and lasting impact’ of COVID-19 on cardiovascular health

Cosmic crime scene: White dwarf found devouring Pluto-like icy world

Major report tackles Covid’s cardiovascular crisis head-on

A third of licensed GPs in England not working in NHS general practice

ChatGPT “thought on the fly” when put through Ancient Greek maths puzzle

Engineers uncover why tiny particles form clusters in turbulent air

GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients

Psoriasis linked to increased risk of vision-threatening eye disease, study finds

Reprogramming obesity: New drug from Italian biotech aims to treat the underlying causes of obesity

Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests

Resistance training may improve nerve health, slow aging process, study shows

Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer

SwRI-built instruments to monitor, provide advanced warning of space weather events

Breakthrough advances sodium-based battery design

New targeted radiation therapy shows near-complete response in rare sarcoma patients

Does physical frailty contribute to dementia?

Soccer headers and brain health: Study finds changes within folds of the brain

Decoding plants’ language of light

UNC Greensboro study finds ticks carrying Lyme disease moving into western NC

New implant restores blood pressure balance after spinal cord injury

New York City's medical specialist advantage may be an illusion, new NYU Tandon research shows

Could a local anesthetic that doesn’t impair motor function be within reach?

1 in 8 Italian cetacean strandings show evidence of fishery interactions, with bottlenose and striped dolphins most commonly affected, according to analysis across four decades of data and more than 5

[Press-News.org] Timing is everything in combination therapy for osteoporosis